本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Addex Therapeutics Ltd

6.60
-0.3910-5.59%
盤後6.45-0.1500-2.27%16:00 EDT
成交量:1,003.00
成交額:6,649.94
市值:813.12萬
市盈率:-0.74
高:6.85
開:6.48
低:6.48
收:6.99
52周最高:12.05
52周最低:5.41
股本:123.20萬
流通股本:104.18萬
量比:0.16
換手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):-8.9530
每股收益(LYR):9.52
淨資產收益率:-72.84%
總資產收益率:-15.90%
市淨率:1.08
市盈率(LYR):0.69

資料載入中...

2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/25

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/19

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/08/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/29

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/10

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/01/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/07

招股説明書

F-1 - Registration statement for certain foreign private issuers
2021/09/08

超過5%披露

Addex Therapeutics Ltd.
2021/04/12

SEC問詢函

CORRESP [Cover] - Correspondence